treatment-related toxicities
Showing 1 - 25 of >10,000
Advanced Renal Cell Carcinoma Trial in Rochester (Carevive software)
Recruiting
- Advanced Renal Cell Carcinoma
- Carevive software
-
Rochester, New YorkUniversity of Rochester - Wilmot Cancer Institute
Jan 4, 2022
Toxicity, Radiation Toxicity Trial in Chapel Hill (Short Chain Fatty Acid, Tapioca Flour)
Not yet recruiting
- Toxicity
- Radiation Toxicity
- Short Chain Fatty Acid
- Tapioca Flour
-
Chapel Hill, North CarolinaOlivia Roberts
Jul 13, 2022
Lymphoma, Lung Cancer, Colo-rectal Cancer Trial in Barrie, Hamilton, Toronto (SMARTCare, Control)
Terminated
- Lymphoma
- +2 more
- SMARTCare
- Control
-
Barrie, Ontario, Canada
- +2 more
Sep 29, 2021
Breast Cancer Nos Metastatic Recurrent Trial in Villejuif (blood sampling)
Recruiting
- Breast Cancer Nos Metastatic Recurrent
- blood sampling
-
Villejuif, FranceGustave roussy
Apr 4, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +20 more
- Best Practice
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 5, 2023
Lung Cancer, Small Cell, Lung Cancer Metastatic, Lung Cancer Recurrent Trial in United States (Nutritional Counseling, Medically
Recruiting
- Lung Cancer, Small Cell
- +5 more
- Nutritional Counseling
- +5 more
-
Boston, Massachusetts
- +3 more
Jul 30, 2021
Toxicities of Salvage Treatment in Locoregionally Recurrent
Not yet recruiting
- Breast Cancer
- Salvage treatment (surgery and/or radiation therapy)
-
Seoul, Korea, Republic ofSamsung Medical Center
Jul 5, 2023
Toxicities in Children and Adults With Cancer
Active, not recruiting
- Macrophage Activation Syndrome
- Primary Hemophagocytic Lymphohistiocytosis
-
Bethesda, MarylandNational Cancer Institute (NCI)
Sep 17, 2022
Oropharyngeal Carcinoma, Immune Checkpoint Inhibitor, De-escalation Trial in Shanghai (Toxicities reduced treatment arm)
Recruiting
- Oropharyngeal Carcinoma
- +2 more
- Toxicities reduced treatment arm
-
Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Apr 27, 2021
Understanding immunE-related toXicities by multifACeT Profiling
Recruiting
- Oncology
-
Chelsea, London, United KingdomRoyal Marsden NHS Foundation Trust
Apr 21, 2022
Toxicities in Soft Tissue Sarcoma of the Extremities - Cohort B
Recruiting
- Soft Tissue Sarcoma of the Extremities
-
Cambridge, United Kingdom
- +2 more
Jul 27, 2023
Radio-induced Toxicities in Treatment of Lung Cancer With
Not yet recruiting
- Lung Cancer
-
Metz, FranceCHR Metz-Thionville/Hopital de Mercy
Jun 5, 2023
Toxicities on Health During Cancer
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Assessment of Therapy Complications
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Mar 16, 2023
Skin Toxicity, Immunotoxicity Trial in Hasselt (Hydrating emollient + body lotion for immunotherapy-related side effects)
Recruiting
- Skin Toxicity
- Immunotoxicity
- Hydrating emollient + body lotion for immunotherapy-related side effects
-
Hasselt, Limburg, BelgiumJessa Ziekenhuis VZW
Dec 2, 2021
Prior Blinatumomab on Subsequent CD19 CAR Outcomes and
Active, not recruiting
- Leukemia, Acute Lymphoblastic
- Lymphoblastic Leukemia, Acute, Childhood
-
Bethesda, MarylandNational Cancer Institute (NCI)
Aug 13, 2022
Skin Toxicity Trial in Hasselt (Self-prepared emollient)
Recruiting
- Skin Toxicity
- Self-prepared emollient
-
Hasselt, Limburg, BelgiumJessa Ziekenhuis VZW
Dec 2, 2021
Oropharyngeal Cancer Trial in Shanghai (Toxicities reduced treatment, Conventional treatment)
Recruiting
- Oropharyngeal Cancer
- Toxicities reduced treatment
- Conventional treatment
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Nov 26, 2023
Reporting of Antibody-Drug Conjugate Associated Sepsis-related
Completed
- Sepsis (SMQ)
- +2 more
- Antibody-Drug Conjugate
- Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
-
Changsha, Hunan, ChinaCentral South University
Jun 19, 2022
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%
Not yet recruiting
- Acneiform Eruption Due to Chemical
- +2 more
- HT-001 2% Topical Gel
- +3 more
- (no location specified)
Dec 3, 2022
Rash Acneiform Trial in Busan (DWP708)
Recruiting
- Rash Acneiform
- DWP708
-
Busan, Korea, Republic ofDong-A University Hospital
May 22, 2022
Patients With Cancer Treated With High-dose Methotrexate
Recruiting
- Acute Kidney Injury
- Drug Toxicity
- High-dose methotrexate
- Glucarpidase
-
Marseille, France
- +4 more
Jun 9, 2023
Peripheral Blood Proteomics to Predict Treatment Response and
Recruiting
- Non Small Cell Lung Cancer
- Blood draw
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
May 10, 2022
Cervical Carcinoma, Endometrial Carcinoma, Endometriosis Trial in Scottsdale, Jacksonville, Rochester (Quality-of-Life
Recruiting
- Cervical Carcinoma
- +3 more
- Quality-of-Life Assessment
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2023
Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer Trial in Pierre-Bénite
Recruiting
- Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer
- Pharmacokinetics, Dosage of Niraparib
-
Pierre-Bénite, FranceHôpital Lyon sud, Institut de Cancérologie des Hospices Civils d
Apr 19, 2022
Pulmonary Toxicities Related to PARP Inhibitors (PulmonaRIB)
Recruiting
- Cancer
- olaparib, rucaparib, niraparib, talazoparib, veliparib, pamiparib
-
Caen, Basse Normandie, FranceAlexandre Joachim
May 27, 2021